Apple's 2026 MacBook Air is largely unchanged on the outside, but its exceptional build pairs up with an even faster M5 chip ...

Gaten Matarazzo's energetic chemistry with Sean Giambrone keeps 'Pizza Movie,' a cheerfully stupid if somewhat overstretched ...

CBQs emphasize real-world decision-making and applied analysis DALLAS, March 11, 2026 /PRNewswire/ -- UWorld Accounting has introduced 28 case-based question sets to its Certified Management ...

The Dell XPS 14 brings the company’s flagship laptop back into competition with speedy Intel Core Series 3 chips and a redesign that’s more practical, yet still premium. In 2022, Dell took a big swing ...

The Food and Drug Administration reversed an earlier decision to not review Moderna's flu vaccine and will evaluate the company's modified application for a potential approval, Moderna said on Feb. 18 ...

The Food and Drug Administration reversed course and agreed to begin a review of Moderna’s MRNA1.16%increase; green up pointing triangle application to sell a new seasonal flu shot after the vaccine ...

The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA flu vaccine candidate after holding a high-priority meeting with the company.

Moderna said Wednesday the Food and Drug Administration changed course and will review an amended application for its new flu vaccine, a week after rejecting the original submission and fueling ...

University of Houston professors could soon be required to self-evaluate their curricula to ensure that course material doesn't promote "personal or institutional advocacy." The five-page proposed ...

The US Food and Drug Administration has reversed course and will review a new mRNA flu vaccine from Moderna, the pharmaceutical company said Wednesday. About two weeks ago, the FDA sent Moderna a ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — The Food and Drug ...

The Food and Drug Administration has reversed course and agreed to review Moderna’s application for the first mRNA-based flu vaccine under a revised approach, company and federal officials said ...